Navigation Links
Neurotechnology Industry Reports Record Global Growth of $130.5 Billion in 2007
Date:5/8/2008

NeuroInsights unveils expanded fourth edition of comprehensive market analysis and strategic investment report at Neurotech Industry Conference

SAN FRANCISCO and BOSTON, May 8 /PRNewswire/ -- NeuroInsights, the neurotech market authority, announced today the release of the organization's fourth annual comprehensive investment guide and market analysis of the global neurological disease and psychiatric illness markets. Unveiled during the annual Neurotech Industry Investing and Partnering Conference in Boston, this 400-page report enables investors, companies and governments to assess opportunities, calculate risks and understand the dynamics of this continually changing market.

The Neurotechnology Industry 2008 Report: Drugs, Devices and Diagnostics for the Brain and Nervous System tracks market movements that help guide strategic business development and investment decisions in neurotech. This year's report provides an in-depth look at more than 16 brain and nervous system disorders and treatments in development at over 500 public and private companies, including: Alzheimer's disease, addiction, ADHD, anxiety, depression, epilepsy, migraine, mild cognitive impairment, multiple sclerosis, obesity, pain, Parkinson's disease, schizophrenia, age-related macular degeneration, sensory disorders, sleep disorders, stroke and traumatic brain injury. Corporate financing, market activity, growth drivers and global industry conditions that make up the obstacles and opportunities facing the industry are fully assessed with detailed insights.

Specific findings from the Neurotechnology Industry 2008 Report show that in 2007:

-- Brain-related illnesses represent the largest unmet medical market with

two billion people worldwide

-- Venture capital investment in neurotechnology reached an all-time high

at $1.77 billion

-- More than 250 investors participated in neurotech financings

-- Global neurotech industry revenues rose 8.3% to $130.5 billion

-- Neuropharmaceuticals recorded revenues of $109 billion and 8% annual

growth

-- Neurodevices recorded revenues of $5.5 billion and 22% annual growth

-- Neurodiagnostics recorded revenues of $16 billion and 6% annual growth

"The neurotechnology industry made substantial gains in 2007, which has continued into 2008," said Casey Lynch, Managing Director of NeuroInsights. "Commercial neuroscience represents one of the fastest-growing and critically needed sectors of the healthcare industry. In 2007, this was underscored in the launch of several important industry initiatives, including the creation of the NASDAQ NeuroInsights Neurotech Index in September."

Specific milestones from the report were presented during NeuroInsights' annual Neurotech Industry Investing and Partnering Conference, hosted in partnership with the Neurotechnology Industry Organization. This conference, being held at the Westin Copley Place in Boston today and tomorrow, is the premier global forum where investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry.

The Neurotechnology Industry 2008 Report: Drugs, Devices and Diagnostics for the Brain and Nervous System is now available for purchase in book or digital format at http://www.neuroinsights.com/marketreports/marketreport2008.html

About NeuroInsights

NeuroInsights is the world's leading neurotechnology research and advisory firm. As the neurotechnology market authority, NeuroInsights helps investors, industry and society understand and profit from the rapid growth in drugs, devices and diagnostics for the brain and nervous system. NeuroInsights provides market reports, investment information, industry events and strategic advisory services to venture funds, startups, corporations, governments and financial institutions. For more information, visit http://www.neuroinsights.com.

Contact:

Casey Lynch

NeuroInsights

(415) 229-3225

casey@neuroinsights.com


'/>"/>
SOURCE NeuroInsights
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Neurotechnology Industry Organization Unveils Top 10 Neuroscience Trends of 2007
2. Alseres Pharmaceuticals, Inc. to Present at The Neurotech Industry Investing & Partnering Conference
3. Facet Solutions, Inc. Appoints Industry Veteran to Board of Directors
4. Anthem Blue Cross and Blue Shield in Connecticut Introduces Industrys First Electronic Tool to Help Members Search In-Network Doctors and Hospitals; Transparency Tool to Enable Searches Via Web-Enabled Cell Phones or Hand-Held Devices
5. Anthem Blue Cross and Blue Shield Introduces Industrys Most Comprehensive Transparency Initiative to Wisconsin
6. Pharma Industry Group Favors Obama as Next President
7. Key Industry and Government Officials to Address Medical Technology Executives
8. China Medicine Corporation Selected to Represent Biotechnology Industry of Guangzhou City at 2008 Annual BIO International Convention
9. The National Association of Specialty Health Organizations to Recognize Excellence in Technology Education With Industry Award
10. Siemens Healthcare Executives Recognized With New Industry Leadership Positions
11. Entertainment Industry Foundation Revlon Run/Walk for Women Celebrates 11 Years in New York City on Saturday, May 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Georgia State University College ... academic programs. , Answering to the increasing demand for curricular specializations, the Certificate ... and environmental and land use law. ,  , “The demand for lawyers with ...
(Date:5/26/2016)... ... May 26, 2016 , ... On Memorial Day, Hope For ... their lives in military battle for the country. The nonprofit Hope For Heroes ... more programs that empower independence for disabled military veterans, as well as police, firemen, ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... one that has a significant negative impact on long-term patient survival, reports a ... The results, published online this week in the Journal of Thoracic and Cardiovascular ...
(Date:5/26/2016)... ... 2016 , ... MadgeTech will be showcasing its line of data logging ... at the MadgeTech headquarters. With products sold in more than 100 countries around the ... NASA. , In 2012, NASA strategically set up 17 RHTemp101A MadgeTech data ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James Maisel will ... Long Island Chapter on June 4, 2016, 1:30-3:30 pm at the Farmingdale Public ... Retina Group of New York , is a Board Certified ophthalmologist who ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... WELLESLEY, Massachusetts , May 26, 2016 ... sequencing (NGS) has matured into an essential life science ... research and development applications. BCC Research reveals in its ... of a second growth phase, one powered by a ... applied fields.      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ...
(Date:5/25/2016)... May 25, 2016 According to ... Type (3D, 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic ... User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to ... Medical Animation Market for the forecast period of 2016 ... 301.3 Million by 2021 from USD 117.3 Million in ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May 25, ... QGEN ; Frankfurt Prime Standard: QIA) today announced that the ... Therawis Diagnostics GmbH to develop and commercialize predictive assays in ... PITX2 as a marker to predict effectiveness of anthracycline treatment ... "We are pleased to partner with Therawis, which developed ...
Breaking Medicine Technology: